The morbidity of @entity6691 suppurativa can be considerable, but little is known about its epidemiology. Our purpose was to describe the one-year and point prevalences of @entity6691 suppurative and its potential precursor lesions. We obtained the histories and examined an unselected sample (599 @entity1 ) of the general population (one-year prevalence), and we performed physical examination for a consecutive sample of 507 @entity1 undergoing screening for @entity2953 (point prevalence). The point prevalence was 4.1% (95% confidence interval [CI] = 3.0-6.0) on the basis of objective findings. The one-year prevalence of @entity6691 was 1.0% (CI = 0.4-2.2) on the basis of subject recollection only. The @entity1 in the sample on which the point prevalence is based were younger than those in the unselected sample of the general population (p < 0.001). @entity6691 was significantly more common in @entity1 (p = 0.037), which may result from a female preponderance of @entity75 (odds ratio [OR] = 5.4; CI = 1.5-19.3). No sex difference was found in the prevalence of @entity75 . @entity6691 suppurativa is significantly more common than hitherto estimated. A female preponderance of @entity1 is confirmed, except for @entity1 with @entity75 . Additional longitudinal studies are necessary to assess the importance of potential precursor lesions such as non-inflamed nodules or comedones.

[Prevalence of XXXX suppurativa in Denmark].

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'persons'] @entity75 :: ('MESH:D001927', 'Disease') :: ['genitofemoral lesions', 'axillary lesions'] @entity6691 :: ('MESH:D016575', 'Disease') :: ['hidradenitis', 'Hidradenitis'] @entity2953 :: ('MESH:D012749', 'Disease') :: ['sexually transmitted diseases']
@entity6691 :: (MESH:D016575,Disease) :: ['hidradenitis']
